ABSTRACT
Multiple emulsions have attracted considerable attention in recent years for application as potential delivery systems for different drugs. The aim of the present work is to design a new formulation containing clotrimazole (CLT) loaded into multiple emulsions by two-step emulsification method for transdermal delivery. Different ingredients and quantities like primary and secondary co-emulsifiers and the nature of oily phase were assayed in order to optimize the best system for good. Resulting formulations were characterized in terms of droplet size, conductivity, pH, entrapment efficiency, rheological behavior, and stability under various storage conditions for 180 days. pH values of multiple emulsions containing CLT ranged from 7.04 ± 0.03 to 6.23 ± 0.04. Droplet size increased when increasing concentration of sorbitan stearate. The addition of polysorbate 80 resulted in significant decrease of oil droplet size comparing with those prepared without this. CLT entrapment efficiency ranged between 85.64% and 97.47%. All formulations exhibited non-Newtonian pseudoplastic flow with some apparent thixotropic behavior. Cross and Herschel-Bulkley equations were the models that best fitted experimental data. In general, the addition of 1% polysorbate 80 resulted in a decrease of viscosity values. No signals of optical instability were observed, and physicochemical properties remained almost constant when samples were stored at room temperature after 180 days. On the contrary, samples stored at 40°C exhibited pronounced increase in conductivity values 24 h after elaboration and some of them were unstable after 180 days of storage. JMLP01 was proposed as an innovative and stable system to incorporate CLT as active pharmaceutical ingredient.
Similar content being viewed by others
REFERENCES
Henry KW, Nickels JT, Edlind TD. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother. 2000;44:2693–700.
Benzaquen LR, Brugnara C, Byers HR, Gatton-Celli S, Halperin JA. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat Med. 1995;1(6):534–40.
Brugnara C, Gee B, Armsby CC, Kurth S, Sakamoto M, Rifai N, et al. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest. 1996;97(5):1227–34.
Ning M, Guo Y, Pan H, Chen X, Gu Z. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm. 2005;31(4-5):375–83.
Isaev NK, Stelmashook EV, Dirnagl U, Andreeva NA, Manuhova L, Vorobjev VS, et al. Neuroprotective effects of the antifungal drug clotrimazole. Neuroscience. 2002;113(1):47–53.
Gemma S, Campiani G, Butini S, Kukreja G, Coccone SS, Joshi BP, et al. Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies. J Med Chem. 2008;51(5):1278–94.
Pedersen M, Bjerregaar S, Jacobse J, Sørensen AM. A genuine clotrimazole (-cyclodextrin inclusion complex-isolation, antimycotic activity, toxicity and an unusual dissolution rate. Int J Pharm. 1998;176:121–31.
Prabagar B, Yoo BK, Woo JS, Kim JA, Rhee JD, Piao MG, et al. Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin. Arch Pharm Res. 2007;30:249–54.
Yong CS, Li DX, Prabagar B, Park BC, Yi SJ, Yoo BK, et al. The effect of cyclodextrin complexation on the bioavailability and hepatotoxicity of clotrimazole. Pharmazie. 2007;62:756–9.
Tonglairoum P, Ngawhirunpat T, Rojanarata T, Kaomongkolgit R, Opanasopit P. Fabrication of a novel scaffold of clotrimazole-microemulsion-containing nanofibers using an electrospinning process for oral candidiasis applications. Colloids Surf B: Biointerfaces. 2015;126:18–25.
Gignone A, Manna L, Ronchetti S, Banchero M, Onida B. Incorporation of clotrimazole in ordered mesoporous silica by supercritical CO2. Micropor Mesopor Mat. 2014;200:291–96.
Souto EB, Müller RH. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams. Pharmazie. 2007;62:505–9.
Ravani L, Esposito E, Bories C, Lievin-Le Moal V, Loiseau PM, Djabourov M, et al. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies Int. J Pharm. 2013;454:695–702.
Ning M, Gu Z, Pan H, Yu H, Xiao K. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole. Indian J Exp Biol. 2005;43:150–7.
Pavelic Z, Skalko-Basnet N, Jalsenjak I. Characterization and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis. Int J Pharm. 2005;301:140–8.
Shahin M, Hady SA, Hammad M, Mortada N. Novel jojoba oil-based emulsion gel formulations for clotrimazole delivery. AAPS PharmSciTech. 2011;12(1):239–47.
Santos SS, Lorenzoni A, Pegoraro NS, Denardi LB, Alves SH, Schaffazick SR, et al. Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole. Colloids Surf B: Biointerfaces. 2014;116:270–6.
Tonglairoum P, Ngawhirunpat T, Rojanarata T, Panomsuk S, Kaomongkolgit R, Opanasopit P. Fabrication of mucoadhesive chitosan coated polyvinylpyrrolidone/cyclodextrin/clotrimazole sandwich patches for oral candidiasis. Carbohydr Polym. 2015;132:173–9.
Schmidts T, Dobler D, Schlupp P, Nissing C, Garn H, Runkel F. Development of multiple W/O/W emulsions as dermal carrier system for oligonucleotides: effect of additives on emulsion stability. Int J Pharm. 2010;398(1-2):107–13.
Silva A, Grossiord JL, Puiseux F, Seiller M. Insulin in W/O/W multiple emulsions: preparation, characterization and determination of stability towards proteases in vitro. J Microencap. 1997;14(3):311–9.
Villar AM, Naveros BC, Campmany AC, Trenchs MA, Rocabert CB, Bellowa LH. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int J Pharm. 2012;431(1-2):161–75.
Celia C, Trapasso E, Cosco D, Paolino D, Fresta M. Turbiscan® Lab Expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf B: Biointerfaces. 2009;72:155–60.
Florence AT, Whitehill D. Formulation and stability of multiple emulsions. Int J Pharm. 1982;11:277–308.
Jiang J, Mei Z, Xu J, Sun D. Effect of inorganic electrolytes on the formation and the stability of water-in-oil (W/O) emulsions. Colloids Surf A. 2013;429:82–90.
Muschiolik G. Multiple emulsions for food use. Curr Opin Colloid Interface Sci. 2007;12:213–20.
Olivieri L, Seiller M, Bromberg L, Besnard M, Duong TN, Grossiord JL. Optimization of a thermally reversible W/O/W multiple emulsion for shear-induced drug release. J Control Release. 2003;88(3):401–12.
Tedajo GM, Seiller M, Prognon P, Grossiord JL. pH compartmented w/o/w multiple emulsion: a diffusion study. J Control Release. 2001;75(1-2):45–53.
Tang SY, Manickam S, Billa N. Impact of osmotic pressure and gelling in the generation of highly stable single core water-in-oil-in-water (W/O/W) nano multiple emulsions of aspirin assisted by two-stage ultrasonic cavitational emulsification. Colloids Surf B: Biointerfaces. 2013;102:653–8.
Geiger S, Tokgoz S, Fructus A, Jager-Lezer N, Seiller M, Lacombe C, et al. Kinetics of swelling-breakdown of a w/o/w multiple emulsion: possible mechanisms for the lipophilic surfactant effect. J Control Release. 1998;52(1-2):99–107.
Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004;278:71–7.
Pal R. Rheology of simple and multiple emulsions. Curr Opin Colloid Interface Sci. 2011;16:41–60.
Krishnaiah YS, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, et al. Development of performance matrix for generic product equivalence of acyclovir topical creams. Int J Pharm. 2014;475(1-2):110–22.
Kawashima Y, Hino T, Takeuchi H, Niwa T, Horibe K. Rheological study of w/o/w emulsions by a cone-and-plate viscometer: negative thixotropy and shear-induced phase inversion. Int J Pharm. 1991;72(1):65–77.
Silva AC, Amaral MH, González-Mira E, Santos D, Ferreira D. Solid lipid nanoparticles (SLN)-based hydrogels as potential carriers for oral transmucosal delivery of risperidone: preparation and characterization studies. Colloids Surf B: Biointerfaces. 2012;93:241–8.
El-Hadidy GN, Ibrahim HK, Mohamed MI, El-Milligi MF. Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation. Drug Dev Ind Pharm. 2012;38(1):64–72.
Schramm G. A practical approach to rheology and rheometry. 2nd ed. Germany: Gebrueder Haake; 1994.
Korhonen M, Lehtonen J, Hellen L, Hirvonene J, Yliruusi J. Rheological properties of three component creams containing sorbitan monoesters as surfactants. Int J Pharm. 2002;247(1-2):103–14.
Wen L, Papadopoulos KD. Osmotic pressure on water transport in w1/o/w2 emulsions. J Coll Interface Sci. 2001;235:398–404.
ACKNOWLEDGMENTS
The authors thank Evonik and Gattefossé for their generous gifts of excipients and formulation advices. In memoriam Prof. Coloma Barbé.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suñer, J., Calpena, A.C., Clares, B. et al. Development of Clotrimazole Multiple W/O/W Emulsions as Vehicles for Drug Delivery: Effects of Additives on Emulsion Stability. AAPS PharmSciTech 18, 539–550 (2017). https://doi.org/10.1208/s12249-016-0529-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-016-0529-8